Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 198

1.

Neutrophil Elastase Inhibition Ameliorates Endotoxin-Induced Myocardial Injury Accompanying Degradation of Cardiac Capillary Glycocalyx.

Fukuta T, Okada H, Takemura G, Suzuki K, Takada C, Tomita H, Suzuki A, Oda K, Uchida A, Matsuo S, Fukuda H, Yano H, Muraki I, Zaikokuji R, Kuroda A, Nishio A, Sampei S, Miyazaki N, Hotta Y, Yamada N, Watanabe T, Morishita K, Doi T, Yoshida T, Ushikoshi H, Yoshida S, Maekawa Y, Ogura S.

Shock. 2019 Nov 19. doi: 10.1097/SHK.0000000000001482. [Epub ahead of print]

PMID:
31764619
2.

Distinctive clinicopathological features and KRAS and IDH1/2 mutation status of cholangiolocellular carcinoma.

Kusano H, Naito Y, Mihara Y, Kondo R, Ogasawara S, Akiba J, Nakashima O, Yano H.

Hepatol Res. 2020 Jan;50(1):84-91. doi: 10.1111/hepr.13428. Epub 2019 Dec 8.

PMID:
31733634
3.

Elevated Expression of EPHA2 Is Associated With Poor Prognosis After Radical Prostatectomy in Prostate Cancer.

Kurose H, Ueda K, Kondo R, Ogasawara S, Kusano H, Sanada S, Naito Y, Nakiri M, Nishihara K, Kakuma T, Akiba J, Igawa T, Yano H.

Anticancer Res. 2019 Nov;39(11):6249-6257. doi: 10.21873/anticanres.13834.

PMID:
31704854
4.

Antiproliferative Effect of Lenvatinib on Human Liver Cancer Cell Lines In Vitro and In Vivo.

Ogasawara S, Mihara Y, Kondo R, Kusano H, Akiba J, Yano H.

Anticancer Res. 2019 Nov;39(11):5973-5982. doi: 10.21873/anticanres.13802.

PMID:
31704822
5.

Histological changes in patients who developed hepatocellular carcinoma after hepatitis C virus eradication by interferon-based therapy.

Kawaguchi T, Ide T, Kondo R, Nomura Y, Arinaga-Hino T, Kuwahara R, Amano K, Sano T, Akiba J, Ohshima K, Yano H, Torimura T.

Exp Ther Med. 2019 Nov;18(5):3991-4001. doi: 10.3892/etm.2019.8024. Epub 2019 Sep 18.

6.

Diverse histomorphology of HER2-positive breast carcinomas based on differential ER expression.

Akashi M, Yamaguchi R, Kusano H, Obara H, Yamaguchi M, Toh U, Akiba J, Kakuma T, Tanaka M, Akagi Y, Yano H.

Histopathology. 2020 Mar;76(4):560-571. doi: 10.1111/his.14003. Epub 2020 Feb 3.

PMID:
31554015
7.

Factors Enhancing Serum Syndecan-1 Concentrations: A Large-Scale Comprehensive Medical Examination.

Oda K, Okada H, Suzuki A, Tomita H, Kobayashi R, Sumi K, Suzuki K, Takada C, Ishihara T, Suzuki K, Kano S, Kondo K, Iwashita Y, Yano H, Zaikokuji R, Sampei S, Fukuta T, Kitagawa Y, Okamoto H, Watanabe T, Kawaguchi T, Kojima T, Deguchi F, Miyazaki N, Yamada N, Doi T, Yoshida T, Ushikoshi H, Yoshida S, Takemura G, Ogura S.

J Clin Med. 2019 Aug 27;8(9). pii: E1320. doi: 10.3390/jcm8091320.

8.

Significance of neoadjuvant chemoradiotherapy for borderline resectable pancreatic head cancer: Pathological local invasion and microvessel invasion analysis.

Naito Y, Ishikawa H, Sadashima E, Okabe Y, Takahashi K, Kawahara R, Hisaka T, Fukahori M, Ushijima T, Ishida Y, Tanigawa M, Mihara Y, Nakayama M, Kondo R, Kusano H, Takase Y, Abe H, Ogo E, Okuda K, Shimamatsu K, Yano H, Akiba J.

Mol Clin Oncol. 2019 Sep;11(3):225-233. doi: 10.3892/mco.2019.1885. Epub 2019 Jun 20.

9.

Programmed death-ligand 1 expression is an unfavorable prognostic factor of hepatocellular carcinoma after archiving sustained virologic response for hepatitis C virus infection.

Kondo R, Akiba J, Ogasawara S, Nakashima O, Naito Y, Kusano H, Mihara Y, Tanigawa M, Yano H.

Oncol Lett. 2019 Aug;18(2):1458-1466. doi: 10.3892/ol.2019.10448. Epub 2019 Jun 7.

10.

KDM2A-dependent reduction of rRNA transcription on glucose starvation requires HP1 in cells, including triple-negative breast cancer cells.

Okamoto K, Tanaka Y, Ogasawara S, Obuse C, Nakayama JI, Yano H, Tsuneoka M.

Oncotarget. 2019 Jul 30;10(46):4743-4760. doi: 10.18632/oncotarget.27092. eCollection 2019 Jul 30.

11.

Sarcomatous Component in Pancreatic Adenosquamous Carcinoma: A Clinicopathological Series of 7 Cases.

Taniwaki S, Hisaka T, Sakai H, Goto Y, Nomura Y, Kawahara R, Ishikawa H, Yasunaga M, Naito Y, Akiba J, Yano H, Tanaka H, Akagi Y, Okuda K.

Anticancer Res. 2019 Aug;39(8):4575-4580. doi: 10.21873/anticanres.13636.

PMID:
31366562
12.

Clinicopathological Study of Resections of Intraductal Papillary Neoplasm of the Bile Duct.

Sato T, Hisaka T, Sakai H, Ishikawa H, Kawahara R, Goto Y, Nomura Y, Yasunaga M, Fujita F, Tanigawa M, Naito Y, Akiba J, Yano H, Tanaka H, Akagi Y, Okuda K.

Anticancer Res. 2019 Aug;39(8):4569-4573. doi: 10.21873/anticanres.13635.

PMID:
31366561
13.

Clinical and Prognostic Significance of Neoplastic Spindle Cells in Gallbladder Cancer.

Midorikawa R, Hisaka T, Sakai H, Nomura Y, Goto Y, Sato T, Kawahara R, Ishikawa H, Fujita F, Yasunaga M, Tanigawa M, Naito Y, Akiba J, Yano H, Tanaka H, Akagi Y, Okuda K.

Anticancer Res. 2019 Aug;39(8):4561-4568. doi: 10.21873/anticanres.13634.

PMID:
31366560
14.

Sinusoidal Obstruction Syndrome and Postoperative Complications Resulting from Preoperative Chemotherapy for Colorectal Cancer Liver Metastasis.

Hisaka T, Ishikawa H, Sakai H, Kawahara R, Goto Y, Nomura Y, Yasunaga M, Kinugasa T, Fujita F, Mizobe T, Fukahori M, Miwa K, Nakashima O, Tanigawa M, Naito Y, Akiba J, Yano H, Tanaka H, Akagi Y, Okuda K.

Anticancer Res. 2019 Aug;39(8):4549-4554. doi: 10.21873/anticanres.13632.

PMID:
31366558
15.

Expression of Matrix Metalloproteinases in Intraductal Papillary Mucinous Neoplasm of the Pancreas.

Akashi M, Hisaka T, Sakai H, Ishikawa H, Kawahara R, Goto Y, Nomura Y, Yasunaga M, Fujita F, Tanigawa M, Naito Y, Akiba J, Yano H, Tanaka H, Akagi Y, Okuda K.

Anticancer Res. 2019 Aug;39(8):4485-4490. doi: 10.21873/anticanres.13623.

PMID:
31366549
16.

Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis.

Tada T, Iijima H, Kobayashi N, Yoshida M, Nishimura T, Kumada T, Kondo R, Yano H, Kage M, Nakano C, Aoki T, Aizawa N, Ikeda N, Takashima T, Yuri Y, Ishii N, Hasegawa K, Takata R, Yoh K, Sakai Y, Nishikawa H, Iwata Y, Enomoto H, Hirota S, Fujimoto J, Nishiguchi S.

Ultrasound Med Biol. 2019 Oct;45(10):2679-2687. doi: 10.1016/j.ultrasmedbio.2019.05.033. Epub 2019 Jul 3.

PMID:
31277922
17.

Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma.

Renne SL, Woo HY, Allegra S, Rudini N, Yano H, Donadon M, ViganĂ² L, Akiba J, Lee HS, Rhee H, Park YN, Roncalli M, Di Tommaso L.

Hepatology. 2020 Jan;71(1):183-195. doi: 10.1002/hep.30814. Epub 2019 Aug 9.

PMID:
31206715
18.

Prognostic impact of p16 and PD-L1 expression in patients with oropharyngeal squamous cell carcinoma receiving a definitive treatment.

Sato F, Ono T, Kawahara A, Kawaguchi T, Tanaka H, Shimamatsu K, Kakuma T, Akiba J, Umeno H, Yano H.

J Clin Pathol. 2019 Aug;72(8):542-549. doi: 10.1136/jclinpath-2019-205818. Epub 2019 May 21.

19.

Neutrophil Elastase Damages the Pulmonary Endothelial Glycocalyx in Lipopolysaccharide-Induced Experimental Endotoxemia.

Suzuki K, Okada H, Takemura G, Takada C, Kuroda A, Yano H, Zaikokuji R, Morishita K, Tomita H, Oda K, Matsuo S, Uchida A, Fukuta T, Sampei S, Miyazaki N, Kawaguchi T, Watanabe T, Yoshida T, Ushikoshi H, Yoshida S, Maekawa Y, Ogura S.

Am J Pathol. 2019 Aug;189(8):1526-1535. doi: 10.1016/j.ajpath.2019.05.002. Epub 2019 May 18.

20.

Malic enzyme 1 is a potential marker of combined hepatocellular cholangiocarcinoma, subtype with stem-cell features, intermediate-cell type.

Mihara Y, Akiba J, Ogasawara S, Kondo R, Fukushima H, Itadani H, Obara H, Kakuma T, Kusano H, Naito Y, Okuda K, Nakashima O, Yano H.

Hepatol Res. 2019 Sep;49(9):1066-1075. doi: 10.1111/hepr.13365. Epub 2019 Jun 18.

PMID:
31077496

Supplemental Content

Loading ...
Support Center